Results 191 to 200 of about 42,053 (270)

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data. [PDF]

Front Cardiovasc Med, 2023
Kim W, Kim M, Kim YT, Park W, Kim JB, Kim C, Joung B.   +6 more
europepmc   +1 more source

Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock-Refractory Out-of-Hospital Cardiac Arrest. [PDF]

J Am Heart Assoc, 2022
Rahimi M, Dorian P, Cheskes S, Lebovic G, Lin S.   +4 more
europepmc   +1 more source

Selective RyR2 inhibition reduces arrhythmia susceptibility in human cardiac slices

The Journal of Physiology, Volume 604, Issue 5, Page 1809-1819, 1 March 2026.
Abstract figure legend ent‐Vert selectively inhibits RyR2‐mediated sarcoplasmic reticulum (SR) Ca2+ leak and prevents triggered activity in human cardiac slices. A, in human ventricular slices exposed to β‐adrenergic stimulation with Iso and RyR2 sensitization with caffeine, RyR2 channels become hyperactive, leading to Ca2+ sarcoplasmic leak and ...
Micah K. Madrid, Katy A. Trampel, Batool Salman, Sharon A. George, Tatiana Efimova, Bjorn Knollmann, Igor R. Efimov   +6 more
wiley   +1 more source

Correction to: Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. [PDF]

Europace
europepmc   +1 more source

Antiarrhythmic drugs in the era of atrial fibrillation ablation. [PDF]

Europace
Boriani G, Mei DA, Imberti JF.
europepmc   +1 more source

SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs. [PDF]

Europace
Wiedmann F, Boondej E, Stanifer M, Paasche A, Kraft M, Prüser M, Seeger T, Uhrig U, Boulant S, Schmidt C.   +9 more
europepmc   +1 more source

Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator [PDF]

Europace
Zylla MM, Wolfes J, Schleberger R, Lawin D, Kieser M, Reinke F, Eckardt L, Rillig A, Stellbrink C, Thomas D, Frey N, Lugenbiel P.   +11 more
europepmc   +2 more sources

Evaluating antiarrhythmic drugs for managing infants with supraventricular tachycardia; a review. [PDF]

Am J Cardiovasc Dis
Mojahedi A, Mirshekari A.
europepmc   +1 more source

Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis. [PDF]

Am J Cardiovasc Drugs
Wattanasukchai L, Bubphan T, Thavorncharoensap M, Youngkong S, Chaikledkaew U, Thakkinstian A.   +5 more
europepmc   +1 more source

Efficacy and safety of different forms of ablation therapies and antiarrhythmic drugs in atrial fibrillation: a systematic review and network meta-analysis of randomized clinical trials. [PDF]

J Thorac Dis
Chen Q, Xiong X, Li L, Gui C.
europepmc   +1 more source